🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
Central nervous system (CNS) idiopathic inflammatory demyelinating diseases...
Status
Recruiting
Location
Beijing Tiantan Hospital
Start Date
2021-12-15
Trial ID
NCT05154370
Treatments Being Tested
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
To investigate whether genotypic differences can be identified between MS p...
Status
Completed
Location
MS Clinic UBC Hospital
Start Date
2010-06
Trial ID
NCT01118130
The purpose of the study is to determine outcomes for Multiple Myeloma pati...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-04-20
Trial ID
NCT05271630
Treatments Being Tested
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
The purpose of the study is to evaluate whether single-agent Elranatamab (P...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2021-02-02
Trial ID
NCT04649359
Treatments Being Tested
Periodontal disease is a multifactorial disease caused by mainly bacterial,...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT03550651
Treatments Being Tested
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136